Reconnect (ZYN2-CL-033): Design of a Phase 3 Trial of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Fragile X Syndrome Based upon Learnings from Connect-Fx (ZYN2-CL-016) Completed during SARS-COV-2 Pandemic
ZYN002
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Reconnect (ZYN2-CL-033): Design of a Phase 3 Trial of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Fragile X Syndrome Based upon Learnings from Connect-Fx (ZYN2-CL-016) Completed during SARS-COV-2 Pandemic ### Output: ZYN002